Revvity reported $1.86B in Current Assets for its fiscal quarter ending in September of 2026.





Current Assets Change Date
Agilent USD 4.69B 70M Jun/2026
Align Technology USD 2.73B 63.03M Sep/2026
Bio Techne USD 824.83M 80.43M Sep/2026
Bio-Rad Laboratories USD 3.08B 58.1M Sep/2026
Bruker USD 2.16B 67.9M Sep/2026
Celltrion KRW 493.66B 12.09B Jun/2026
Charles River Laboratories USD 1.54B 5.92M Sep/2026
Cspc Pharmaceutical CNY 22.25B 359.48M Dec/2025
Danaher USD 14.79B 1.41B Sep/2026
Dentsply International USD 1.98B 50M Sep/2026
Deva Holding AS TRY 9.13B 1.61B Sep/2023
Dianthus Therapeutics USD 856.04M 41.5M Sep/2026
Divis Laboratories Ltd INR 124.39B 13.43B Sep/2026
Edwards Lifesciences USD 7.25B 428.6M Sep/2026
Illumina USD 3.04B 201M Sep/2026
Intuitive Surgical USD 10.65B 1.68B Sep/2026
IQVIA Holdings USD 6.45B 225M Sep/2026
Kangmei Pharma CNY 6.66B 143.43M Jun/2026
Knight Therapeutics CAD 394.84M 5.86M Dec/2025
Laboratorios Farma EUR 509.33M 128.63M Dec/2023
Laboratory Of America USD 3.97B 151.3M Sep/2026
Malin Corporation EUR 62.6M 26.7M Dec/2024
Medical Developments International AUD 33.75M 1.79M Dec/2025
Mesa Laboratories USD 105.63M 8.2M Dec/2025
Mettler Toledo International USD 1.38B 28.79M Sep/2026
Myriad Genetics USD 289M 23.8M Jun/2026
Neuren Pharmaceuticals AUD 332.23M 11.98M Dec/2025
OraSure Technologies USD 222.94M 17.84M Jun/2026
Organigram Holdings CAD 280.09M 30M Jun/2026
Ovoca Bio EUR 2.07M 510K Dec/2025
Pacific Biosciences Of California USD 307.85M 30.78M Sep/2026
Pharma Mar EUR 295.56M 14.62M Sep/2026
Qiagen NV USD 1.66B 116.37M Jun/2026
Quest Diagnostics USD 3.12B 273M Sep/2026
Quidel USD 1.45B 69.4M Sep/2026
Repligen USD 1.24B 41.43M Sep/2026
Revvity USD 1.86B 436.33M Sep/2026
Sartorius EUR 1.65B 8.4M Sep/2026
Sino Biopharmaceutical CNY 33.82B 9.13B Jun/2025
Thermo Fisher Scientific USD 25.62B 2.25B Sep/2026
Tilray USD 729.32M 28.18M Sep/2025
Waters USD 3.9B 186M Jun/2026
Zealand Pharma A/S 15.02B 652.12M Mar/2026
Zz Pientze Pharmaceu CNY 13.48B 2.32B Sep/2026